The innovative research conducted by our physicians and faculty has paved the way for more effective methods of prevention, diagnosis, and treatment of gastrointestinal diseases.
Dr. Robert Fontana discusses his study that has global impact on Hepatitis C elimination efforts.
In our mission to create knowledge through research, the Division of Gastroenterology and Hepatology continues to conduct cutting-edge investigations of the molecular, cellular, and physiological conditions of healthy and diseased states of the gastrointestinal tract, liver, and pancreas. The central piece of the Division's research endeavor is the NIH-funded University of Michigan Center for Gastrointestinal Research, which encompasses three thematic areas of research:
- neurobiology of appetite control and visceral pain
- molecular and cellular mechanisms of inflammation
- cell growth, differentiation, and programmed cell death
Research Highlights
April 14, 2021
Feasibility and Early Experience of a Novel Multidisciplinary Alcohol-associated Liver Disease Clinic
Jessica Mellinger, MD, MSc explores the benefits of starting a multidisciplinary ALD clinic for patients.
March 8, 2021
Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome
Pratima Sharma, MBBS, MS conducts a phase 3 trial to confirm the efficacy and safety of terlipressin plus albumin in adults with type 1 hepatorenal syndrome.
February 23, 2021
New Study Suggests Excess Glycogen May Cause Metabolic Syndrome
Elizabeth Speliotes, MD, PhD, MPH leads a team of experts to explore the possible association between genetic variants in the human genome and liver attenuation.
January 4, 2021
Similar Factors Cause Health Disparities in Cancer and COVID-19
John M. Carethers, MD discusses the similar disparities occurring in cancer and COVID-19 in paper published by Clinical Cancer Research.
